Guerda Johnson, FNP-C knows that no two bodies respond the same way to nutrition or movement, especially as we age
The prevalence of mutations associated with this condition reach 68% to 81% in certain arctic coastal populations, suggesting that the condition had some adaptive value in those habitats at some time
For patients taking semaglutide who have not achieved desired weight loss, ensuring adequate dose titration to the maximum tolerated dose (2.4 mg weekly for Wegovy) and allowing sufficient treatment duration (at least 16-20 weeks) is essential before adding additional pharmacotherapy
Research on skeletal muscle adaptations in Long COVID patients has revealed intrinsic mitochondrial dysfunction, endothelial abnormalities, and a muscle fiber type shift towards a more glycolytic phenotype
GLP-1 receptor agonists have demonstrated improvements in mental health-related quality of life in clinical trials
Who Should Take Which Supplement